ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer

Zhou, Yue; Zhang, Qing; Wang, Minjia; Huang, Chengzhi*; Yao, Xueqing*广东省人民医院; 南方医科大学
Frontiers in Oncology2022-2-21DOI: 10.3389/fonc.2022.827891
5被引6阅读
引用收藏
分享

摘要

Chemotherapy resistance represents a formidable obstacle in advanced or metastatic colorectal cancer (CRC) patients. It is reported that ATPase copper transporting alpha (ATP7A) plays an important role in chemotherapy resistance in CRC. Here, we identified ATP7A as a potentially key gene of OXA resistance in CRC. The patients with higher expression of ATP7A tended to have platinum drug resistance. While the lower expression of ATP7A by siRNA knockdown resulted in enhancement of OXA sensitivity and increased OXA-induced apoptosis. Further, we demonstrated a novel and safe strategy to increase CRC chemosensitivity by delivering siRNA into tumor cells via a novel nanoparticle, DAN. In summary, our study provided a novel nanocarrier-based delivery of ATP7A to interfere in a key gene of chemo-resistance in CRC, which may be a novel therapeutic strategy to overcome chemotherapy resistance in CRC.

学科与关键词

关键词
oxaliplatinchemoresistancesiRNA deliverycolorectal cancerATP7A
相关
加载中…
  • Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer (vol 12, 827891, 2022)
    Zhou, Yue; Zhang, Qing; Wang, Minjia; Huang, Chengzhi*; Yao, Xueqing*Frontiers in Oncology, 2022, 12: 916983.被引 1
  • Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer
    Huang, Cheng-Zhi; Zhou, Yue; Tong, Qi-Song; Duan, Qi-Jia; Zhang, Qing; Du, Jin-Zhi*; Yao, Xue-Qing*Biomaterials, 2022, 290: 121827.被引 8
  • Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer
    Hashemi, Mehrdad; Esbati, Nastaran; Rashidi, Mohsen; Gholami, Sadaf; Raesi, Rasoul; Bidoki, Seyed Shahabadin; Goharrizi, Mohammad Ali Sheikh Beig; Motlagh, Yasamin Sadat Mousavi; Khorrami, Ramin; Tavakolpournegari, Alireza; Nabavi, Noushin; Zou, Rongjun; Mohammadnahal, Leila*; Entezari, Maliheh*; Taheriazam, Afshin*; Hushmandi, Kiavash*Translational Oncology, 2024, 40: 101846.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-02-21
卷期
第 12 卷
页码
827891
DOI
10.3389/fonc.2022.827891
期刊等级
3区
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangdong Provincial Peoples Hospital (Guangdong Academy of Medical Sciences) [DFJH201913]; CSCO-Roche Cancer Research Foundation [Y-2019Roche-190]; CSCO-Haosen Research Foundation [Y-HS2019/2-050]; Science and Technology Planning Project of Ganzhou [202101074816]

作者

  • Z

    Zhou, Yue (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • Z

    Zhang, Qing

    guangdong prov peoples hosp · 2 · southern med univ

查看全部 5 位作者收起作者
  • W

    Wang, Minjia

    2 · southern med univ · guangdong prov peoples hosp

  • H

    Huang, Chengzhi (通讯)

    guangdong prov peoples hosp

  • Y

    Yao, Xueqing (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417